Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | HTR3A | P46098 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | HTR1B | P28222 | 2/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.33 |
| ▸ | AGXT | P21549 | 1/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29716667 | 1.00 | SLC6A2 (0.38) | SLC6A2SLC6A4HTR3AKCNH2CYP2D6 | |
| SCHEMBL15282630 | 0.83 | HTR1B (0.50) | SLC6A4KCNA3ALDH1A1HTR1B | |
| SCHEMBL15282629 | 0.81 | SLC6A2 (0.55) | SLC6A2SLC6A4HTR3AKCNH2SLC6A3 | |
| SCHEMBL29354355 | 0.79 | ALDH1A1 (0.61) | SLC6A2SLC6A4HTR3AKCNH2CYP2D6 | |
| SCHEMBL16258166 | 0.79 | ALDH1A1 (0.61) | SLC6A2SLC6A4HTR3AKCNH2CYP2D6 | |
| SCHEMBL24942524 | 0.79 | ALDH1A1 (0.61) | SLC6A2SLC6A4HTR3AKCNH2CYP2D6 | |
| SCHEMBL23171858 | 0.79 | ALDH1A1 (0.61) | SLC6A2SLC6A4HTR3AKCNH2CYP2D6 | |
| SCHEMBL45820 | 0.79 | ALDH1A1 (0.61) | SLC6A2SLC6A4HTR3AKCNH2CYP2D6 | |
| SCHEMBL25388727 | 0.79 | HTR1B (0.35) | SLC6A4KCNA3ALDH1A1HTR1B | |
| SCHEMBL1402715 | 0.77 | ALDH1A1 (0.55) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114986-A1 | CURABLE COMPOSITION FOR MECHANICAL FOAMING AND METHOD FOR MANUFACTURING FOAM OF THE SAME | THREE BOND CO LTD (JP) | 2025-04-10 | — | — | US | disclosed |
| US-20230340330-A1 | COMPOSITION FOR COLOR CONVERSION FILM, COLOR CONVERSION FILM, METHOD FOR MANUFACTURING COLOR CONVERSION FILM, BACKLIGHT UNIT, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20220355517-A1 | CURABLE COMPOSITION FOR MECHANICAL FOAMING AND METHOD FOR MANUFACTURING FOAM OF THE SAME | THREEBOND CO., LTD. (JP) | 2022-11-10 | — | — | US | disclosed |
| US-11155669-B2 | Curable resin composition, cured product thereof, and bonded body bonded by cured product | THREEBOND CO., LTD. (JP) | 2021-10-26 | — | — | US | disclosed |
| EP-3885399-A1 | CURABLE COMPOSITION FOR MECHANICAL FOAMING, AND METHOD FOR MANUFACTURING FOAM OF SAME | ThreeBond Co., Ltd. (JP) | 2021-09-29 | — | — | EP | disclosed |
| US-20190211132-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT THEREOF, AND BONDED BODY BONDED WITH CURED PRODUCT THEREOF | THREEBOND CO., LTD. (JP) | 2019-07-11 | — | — | US | disclosed |
| CN-101687979-B | Resin composition | AJINOMOTO CO.,INC. (JP) | 2016-03-02 | — | — | CN | disclosed |
| EP-2698393-B1 | Resin composition | AJINOMOTO KK (JP) | 2015-08-19 | — | — | EP | disclosed |
| US-9018321-B2 | Resin composition | AJINOMOTO CO., INC. (JP) | 2015-04-28 | — | — | US | disclosed |
| CN-104334601-A | Curing agent for anionic curable compound, curable composition, cured product, novel imidazole compound, and use thereof | NIPPON SYNTHETIC CHEM IND | 2015-02-04 | — | — | CN | disclosed |
| CN-103739827-A | Resin composition | AJINOMOTO KK | 2014-04-23 | — | — | CN | disclosed |
| EP-2698393-A1 | Resin composition | Ajinomoto Co., Inc. (JP) | 2014-02-19 | — | — | EP | disclosed |
| EP-2174969-A1 | RESIN COMPOSITION | Ajinomoto Co., Inc. (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20090030158-A1 | RESIN COMPOSITION | AJINOMOTO CO., INC (JP) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030158-A1 | RESIN COMPOSITION | PPA1, PTGER1, TAF5 | SLC6A2 2460/4885SLC6A4 3254/4885HTR3A 3768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.